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The accumulation of cleaved tau fragments in the brain is associated with several tauopathies. For this
reason, we recently developed a transgenic mouse that selectively accumulates a C-Terminal 35 kDa hu-
man tau fragment (Tau35). These animals develop progressive motor and spatial memory impairment,
paralleled by increased hippocampal glycogen synthase kinase 3b activity. In this neurophysiological
study, we focused on the CA1 subﬁeld of the hippocampus, a brain area involved in memory encoding. The
accumulation of Tau35 results in a signiﬁcant increase of short-term facilitation of the synaptic response in
the theta frequency range (10 Hz), without affecting basal synaptic transmission and long-term synaptic
plasticity. Tau35 expression also alters the intrinsic excitability of CA1 pyramidal neurons. Thus, Tau35
presence is associated with increased and decreased excitability at hyperpolarized and depolarized po-
tentials, respectively. These observations are paralleled by a hyperpolarization of the voltage-sensitivity of
noninactivating Kþ currents. Further investigation is needed to assess the causal link between such
functional alterations and the cognitive and motor impairments previously observed in this model.
 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
A range of neurodegenerative tauopathies in humans are char-
acterized by the progressive accumulation of pathogenic tau ag-
gregates within the central nervous system (CNS). These conditions
are associated with diverse clinical outcomes, which may consist of
both cognitive and motor impairments, as extensively reviewed
(Goedert and Spillantini, 2011; Lee et al., 2001; Spillantini and
Goedert, 2013). Alzheimer’s disease represents the most common
form of tauopathy. Its pathological outcomes coexist with, and may
be a consequence of, amyloidopathy (Hardy and Allsop,1991; Hardy
and Higgins, 1992). Neurodegenerative diseases that are purely
associated with the progressive accumulation of tau protein spe-
cies, include frontotemporal dementia (FTD), progressive supra-
nuclear palsy (PSP), and corticobasal degeneration (CBD). PSP is
characterized histopathologically by neurodegeneration of
midbrain and brainstem structures, including hypothalamus and
basal ganglia (Pollock et al., 1986) and clinically by postural insta-
bility (Steele et al., 1964).pkins Building, University of
, UK. Tel.: þ44 (0) 118 378
agnini).
Inc. This is an open access articleIn tauopathy, the tau protein can be subjected to a range of
disease-associated posttranslational modiﬁcations, the most
explored one being its phosphorylation. The altered phosphoryla-
tion of tau protein leads to the formation of neuroﬁbrillary tangles,
and the occlusion of its ability to interact with microtubules;
hyperphosphorylated tau is associated with all the previously
mentioned neurodegenerative conditions (Spillantini and Goedert,
2013). Ubiquitination and tau truncation are also characteristic
modiﬁcations observed in human tauopathies (Martin et al., 2011).
The majority of tauopathies are sporadic, and some lines of ev-
idence suggest that the accumulation of tau fragments plays a part
in the pathogenesis of some or all of these conditions. For instance,
we previously identiﬁed a N-terminally truncated form of tau in
human brain that is highly phosphorylated and associated with the
development of 4-repeat forms of human tauopathy, such as PSP
(Guo et al., 2017; Wray et al., 2008). This work on human disease
tissues was followed-up by the production of a novel mouse model
inwhich the brain-derived, C-terminal 35 kDa tau fragment (Tau35)
was expressed under the control of the human tau promoter
(Bondulich et al., 2016). The expression of the construct was
introduced into the mouse hypoxanthine phosphoribosyl trans-
ferase (Hprt) locus (Bronson et al., 1996), guaranteeing single copy
targeted integration. This both eliminates potential gene disruptionunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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expression. Correspondingly, in this animal, the Tau35 transgene
was only expressed at a low level, accounting for less than 10% of
the level of endogenous mouse tau.
Tau35 mice progressively develop a number of key aspects of hu-
man tauopathies. These include the appearance of aggregated and
abnormally phosphorylated tau, increased glycogen synthase kinase
3b (GSK3b) activity, deﬁcits in cognitive and motor function, prema-
ture death, dysfunction associated with autophagy and lysosomal
processing, and a decline in synaptic protein levels. Cognitive decline
was revealed in Tau35 mice by an age-dependent impairment in their
performance in theMorriswatermaze, awell-validated hippocampal-
dependent spatial memory task (Bondulich et al., 2016).
This work examines the neurophysiological function of the Tau35
mouse in the CA1 subﬁeld of the hippocampus, an area with a well-
established role in spatial navigation and memory (Chersi and
Burgess, 2015). The experiments were all performed on mice aged
14e18 months. This is an age beyond which water maze learning is
eliminated and is the age point at which biochemical and immuno-
histochemical measurements revealed a number of key alterations to
hippocampal neurochemistry. These include tangle-like structures
reactive for a broad range of tau antibodies, changes to tau phos-
phorylation, increased GSK-3b activity, altered levels of synaptic pro-
teins, and modiﬁcations indicative of altered autophagic processing
(Bondulich et al., 2016). Our experiments reveal that, as seen in other
models of tauopathy (Booth et al., 2016b), long-term synaptic plas-
ticity is unaltered in the Schaffer collateral commissural pathway.
However, we did observe genotype-associated changes to short-term
synaptic plasticity and intrinsic excitability properties of CA1 pyra-
midal neurons thatmay contribute to the loss of spatial memory these
mice exhibit.2. Materials and methods
2.1. Experimental animals
In all experiments, animals expressing the Tau35 transgene
were compared against age-matched wild-type littermate controls
(36 animals; 17WT, 19 TG). Fig. 1 shows a schematic representation
of the Tau35 fragment compared to human tau; this is the product
of the expression of the Tau35 genetic construct described in our
previous work (Bondulich et al., 2016). Animals were bred at King’s
College London and arrived in a single shipment to the University of
Exeter Medical School prior to the commencement of the study.
They were group housed, allowed food and water ad libitum and
maintained on a 12:12 hours light/dark cycle. This study was car-
ried out in accordance with UK Home Ofﬁce Guidelines and the
King’s College London and University of Exeter Animal Welfare
Ethical Review Board.2.2. Preparation of brain slices
Animals were sacriﬁced using cervical dislocation in accordance
with Schedule 1 of the Animals (Scientiﬁc Procedures) Act (1986).
The brain was rapidly removed and transferred to an ice coldFig. 1. Schematic representation of the Tau35 fragment in comparison to full-length human
N-terminal inserts, followed by a proline-rich domain and 4 microtubule binding repeats
human tau fused at the C-terminus to a hemagglutinin tag (HA). Abbreviations: CNS, centrcutting solution consisting of (in mM): 189 sucrose, 10 D-glucose,
26 NaHCO3, 3 KCl, 5 MgSO4(7H2O), 0.1 CaCl2, and 1.25 NaH2PO4.
About 300-mm coronal sections were cut using a Leica VT1200
microtome and immediately transferred to a holding chamber
containing artiﬁcial cerebrospinal ﬂuid (aCSF) continuously
bubbled with carbogen. The composition of the aCSF was as follows
(in mM): 124 NaCl, 3 KCl, 24 NaHCO3, 2 CaCl2, 1.25 NaH2PO4, 1
MgSO4, and 10 D-glucose. The slices were then allowed to recover
for 30 minutes at 37 C and subsequently at room temperature for
at least 1 hour before transfer into a recording chamber. Field po-
tential and whole-cell recording experiments were carried out on
different brain slices.2.3. Whole-cell patch-clamp recordings
Slices were transferred to a recording chamber where they were
submerged in carbogen-equilibrated aCSF and maintained at a
temperature between 33 Ce34 C. The recording chamber was
secured on the stage of an Olympus BX51 upright microscope and
individual CA1 pyramidal neurons were visualized using infrared
differential interference contrast optics. Borosilicate glass micro-
electrodeswith a resistance ranging from3e5MUwere pulled, ﬁre-
polished, and ﬁlled with a K-gluconateebased internal solution
consisting of (in mM): 135 K-gluconate, 5 NaCl, 10 HEPES free acid,
0.2 EGTA, 0.3 Na-GTP, 4 Mg-ATP, and 13.4 Biocytin (pH 7.3, 280e290
mOsm). Following entry into whole-cell conﬁguration, a junction
potential error of 15 mV arose due to the pairing of the pipette
solution with the aCSF, which was arithmetically corrected for
during analysis. Signals were recorded using a Multiclamp 700B
ampliﬁer, digitized using a Digidata 1440, and stored for future
analysis using pClamp 10 software.
All recordings were made from a deﬁned prestimulus mem-
brane potential set by injecting a continuous ﬂow of bias current
through the recording electrode. This facilitated the analysis of
passive neuronal properties and action potential (AP) generation
from prestimulus membrane potentials (Vm) of both 80
and 74 mV. To measure neuronal passive membrane properties, a
500 ms, 100 pA hyperpolarizing current step was injected across
the membrane from each Vm. The subsequent voltage deﬂection at
the steady state of the hyperpolarization was used to calculate the
input resistance (Rin) of the membrane using Ohm’s law (V ¼ IR).
The extrapolation of a single exponential curve at an inﬁnite time,
ﬁtted to the membrane charging response between 10% and 95% of
the peak amplitude, was used to calculate the membrane time
constant (s). An approximation of capacitance was measured as the
ratio between the s and Rin. Sag, measured as the difference be-
tween the negative peak and the steady state hyperpolarization,
was expressed as a percentage of the peak hyperpolarization in
response to a 500 ms, 100 pA hyperpolarizing current injection.
Standard “Zap” protocols were used to measure subthreshold
membrane resonance properties, as previously described (Hu et al.,
2002; Tamagnini et al., 2014). Brieﬂy, the ratio of the fast Fourier
transform of the voltage response versus the current injection was
calculated as a measure of the impedance proﬁle of the pyramidal
neurons (Z ¼ Vfft/Ifft). Subsequently, the impedance versustau. Tau is alternatively spliced, and the largest CNS isoform of human tau comprises 2
(2N4R tau, 441 amino acids). The Tau35 sequence includes residues 187-441 of 2N4R
al nervous system; Tau35, C-Terminal 35 kDa human tau fragment.
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function (sZ). Cell-to-cell maximal impedance (Z max, MU),
frequency at which this maximal impedance occurred (Peak fre-
quency, Hz), quality factor of the resonator (Q), and area under the
curve (AUC, sZ*Fr) were quantiﬁed to facilitate comparisons
between the genotypes.
To quantify neuronal excitability, a series of incremental 500 ms
depolarizing square current injections, ranging from 50e300 pA,
were injected across the membrane. The number of AP generated
for each current injectionwas used as a measure of excitability. The
pattern of neuronal ﬁring was also examined by plotting the
instantaneous frequency between APs versus the interval number.
The ﬁrst AP ﬁred in response to a 300 pA depolarizing current step
was used to compare AP waveforms between the genotypes. AP
threshold was quantiﬁed, deﬁned as the voltage at which the rate of
rise (dV/dt) surpassed 20 V*s1. AP width was measured at15mV,
whereas the AP rate of rise (RoR) was measured for each cell as the
rate of rise of the membrane potential at 20 mV during the rising
phase of the AP.
Short-term plasticity was measured by evoking a train of 6
excitatory postsynaptic potentials (EPSPs) at 1 Hz, 3 Hz, 10 Hz, and
30 Hz. Each individual EPSP was elicited by delivering a 0.1 ms
current pulse through a tungsten bipolar stimulating electrode
placed on axons of the Schaffer collateral pathway. Stimulus in-
tensity was set to produce measurable EPSPs without reaching
threshold for triggering an AP. To analyze the relative increase in
EPSP amplitude during the pulse train each value was normalized
to the amplitude of the EPSP evoked by the ﬁrst stimulus in the
train and the area under curve was calculated for each cell: for each
stimulation frequency, data were compared between genotypes.
For voltage clamp experiments, outside-out, somatic, nucleated
macropatches were excised as previously described (Brown et al.,
2011). Pipette capacitance was neutralized, and the series resis-
tance was compensated for (10%e80% correction). Voltage-clamp
recordings were made for the quantitative evaluation of outward-
going plateau voltage-gated Kþ currents, by applying 30-ms
voltage steps, growing in 10-mV increments, and starting from a
holding voltage of 90 mV. Each recorded current amplitude was
normalized to the membrane capacitance of the macropatch to
account for differences in current amplitude arising from different
sizes of the macropatch. The speciﬁc current (pA/pF) was used to
calculate the speciﬁc conductance to Kþ ions based on a Nernstian
equilibrium potential of 100 mV.
2.4. Field excitatory postsynaptic potentials
Following the initial postslicing recovery period, the CA3 region
of hippocampal slices was removed using a scalpel cut. Slices were
then transferred to a recording chamber in which they were sub-
merged in continually perfused aCSF pre-equilibrated with carb-
ogen and maintained at a temperature between 32 Ce33 C. Field
excitatory postsynaptic potentials (fEPSPs) were elicited by deliv-
ering a short pulse of electrical current (0.1 ms) through tungsten
bipolar stimulating electrodes. These stimulating electrodes were
placed such as to stimulate axons of the Schaffer Collateral (SC) or
temporoammonic (TA) pathways. Borosilicate glass recording mi-
croelectrodes with a resistance ranging from 3e5 MU were pulled
and ﬁlled with aCSF. Recorded signals were collected with an
Axoclamp 2B ampliﬁer, digitized with a Digidata 1322A, and stored
for future analysis using pClamp 10 software.
For the majority of input-output curves and long-term potenti-
ation (LTP) experiments, the SC and TA pathways were stimulated
alternatively every 15 seconds; however, in some cases, experi-
ments focused on an individual pathway. Input-output curves were
constructed by incrementally increasing the current passingthrough the stimulating electrode and recording the evoked
response (25e300 mA in 25 mA steps for the SC pathway,
125e1500 mA in 125 mA steps for the TA pathway). Following this,
the threshold stimulation intensity required to elicit a visually
detectable fEPSPwas found. The stimulus intensity was then set at 3
times the threshold level for the remainder of the recording.
After a period of at least 20 minutes recording baseline
responses at low frequency, induction of LTP was attempted in one
pathway using a thetaburst stimulation protocol. This consisted of 5
bursts of 10 stimuli at 100 Hz applied with an interburst interval of
200 ms. This was repeated 4 times with an inter-repeat interval of
20 seconds. The fEPSPs were then followed for 1 hour before the
thetaburst stimulation protocol was delivered to the other pathway
and fEPSPs were followed for another hour. The order in which the
pathways were stimulated was alternated between experiments.
2.5. Data analysis
Data were analyzed using a range of custom written MATLAB
scripts, pClamp, and Origin 9.1 analysis tools. The approaches used
for the analysis of intrinsic properties are described in the study by
Tamagnini et al. (2014). Statistical assessments of differences be-
tween genotypes were made using unpaired 2-tailed Student t tests
(with or without Bonferroni correction -bc- for multiple compari-
sons) and 2-way analysis of variance (ANOVA) as appropriate; non-
parametric Mann-Whitney U test was used for normalized data.
Figures were prepared with Origin 9.1. Data are shown as
mean  standard error of the mean (SEM) values.
3. Results
High levels of 35 kDa cleaved tau protein (Tau35) have been
found in the brain of patients affected by PSP (Wray et al., 2008). By
performing electrophysiological recordings in the CA1 subﬁeld of
the dorsal hippocampus of 14- to 18-month old Tau35 mice and
age-matched littermate controls, our study aimed to characterize
the functional neurophysiological consequences of chronic expo-
sure to C-terminal 35 kDa fragments of tau protein. First, we used
extracellular ﬁeld potential recordings to examine synaptic trans-
mission and long-term plasticity at excitatory synapses in the CA1
subﬁeld of the hippocampus. Historically, this has unquestionably
been the most commonly made assessment of neurophysiological
function in rodent models of human dementia (Randall et al., 2010).
To parallel other recent studies in our laboratory (Booth et al., 2014,
2016b), we looked at both Schaffer collateral (SC)-CA1 and tem-
poroammonic (TA) synaptic function. Contemporaneously, but on
separate slices, we employed whole-cell patch-clamp recordings
from single CA1 pyramidal cells to assess both short-term synaptic
plasticity on SC-CA1 synapses and the intrinsic excitability mem-
brane properties of CA1 excitatory pyramidal neurons.
Extracellular recordings of evoked ﬁeld EPSPs revealed no dif-
ference in basal synaptic transmission in either pathway (data not
shown; CA1-SCe2-way repeated measures [RM] ANOVA, source of
variability ¼ genotype, F ¼ 0.95, p ¼ 0.35; TA-CA1e2-way RM
ANOVA, source of variability ¼ genotype, F ¼ 1.45, p ¼ 0.26). We
also observed no difference in the ability to induce LTP in either SC-
CA1 or TA-CA1 synapses (Fig. 2; SC-CA1eMann-Whitney U Test,
source of variability ¼ genotype; p ¼ 0.4; TA-CA1eMann-Whitney
U Test, source of variability ¼ genotype, p ¼ 0.46) in Tau35 mice
when compared with their WT littermate controls.
In addition, whole-cell patch-clamp recordings of EPSPs in CA1-
PCs, evoked by the repeated stimulation of SC ﬁbers (6 pulses
delivered at 1 Hz, 3 Hz, 10 Hz, and 30 Hz), revealed an increase in
short-term synaptic plasticity in Tau35 mice. This was apparent at a
stimulus frequency of 10 Hz, a frequency within the theta band
Fig. 2. Long-term potentiation (LTP) in CA1 of hippocampal slices prepared from Tau35 mice is normal. (A) Average trace of an evoked fEPSP during the baseline (black) and ﬁnal
20 minutes (gray) of a single SC LTP experiment. (B) Sample traces of the theta burst induction protocol were used to induce LTP. (C) Extracellular recordings of evoked fEPSPs in
hippocampal CA1 do not show differences in LTP induction between Tau35 and age-matched WT littermate controls. We tested 2 different pathways to CA1: the schaffer collateral
(SC) pathway (top panel) and the temporoammonic (TA) pathway (bottom panel). Abbreviations: fEPSP, ﬁeld excitatory postsynaptic potential; Tau35, C-Terminal 35 kDa human tau
fragment.
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Mann-Whitney U test, source of variability ¼ genotype; 1 Hz,
p ¼ 0.829; 3 Hz, p ¼ 0.193; 10 Hz, p ¼ 0.018; and 30 Hz, p ¼ 1).
We, and others, have described differences in intrinsic excit-
ability membrane properties of hippocampal neurons in a number
of murine models of human dementia (Brown et al., 2011; Kerrigan
et al., 2014; Siskova et al., 2014; Tamagnini et al., 2015a,b; Wykes
et al., 2012), including models of FTD (Booth et al., 2016b). Conse-
quently, we compared intrinsic excitability properties of Tau35 and
WT control mice using whole-cell current-clamp recordings from
CA1-PCs. No differences were observed in the resting membrane
potential (RMP) (Fig. 4; Tau35, RMP ¼ 76.6 mV  1.3 mV n ¼ 47
andWT, RMP¼74.1 mV 1.6 mV n¼ 32, unpaired Student’s t test
p ¼ 0.2). To avoid biases arising from cell-to-cell variability in RMP,Fig. 3. Increased facilitation of the excitatory synaptic transmission in the SC-CA1 pathway
showing 6 evoked EPSPs from 2 patch-clamp, current-clamp recordings in CA1-PCs from W
delivering the stimuli on the SC pathway at 10 Hz (theta range). (B) Each cell received a comp
range). Although no differences between genotypes were observed at 1 Hz, 3 Hz, and 30 Hz
CA1-PCs showed sustained facilitation along all of 6 pulses, whereas WT controls came b
potentials; Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse. (For interp
version of this article.)all the other intrinsic excitability properties were measured from 2
ﬁxed prestimulus Vm, 80 mV and 74 mV, respectively. These
prestimulus levels were established with a suitable level of bias
current injection. We chose to record the intrinsic excitability
properties from the 2 different prestimulus potentials as wewanted
to gather information on the intrinsic excitability properties arising
from a potential that was (1) close to the average value RMP
(i.e., 74 mV) and (2) sufﬁciently hyperpolarized to measure sub-
threshold oscillatory properties of the cell (i.e., 80 mV).
The hyperpolarization response resulting from the injection of
a 100 pA, 500 ms square current step, allowed us to measure
membrane passive properties, such as Rin, s, and capacitance of the
membrane. This response also allowed us to measure the
Ihedependent “sag”, we have found to be altered in rTg4510 mice, aat theta range (10 Hz) stimulation frequencies in Tau35 CA1-PCs. (A) Example traces
T (top-black) and Tau35 (bottom-red) mice; in this case, facilitation was obtained by
lete set of stimulus frequencies: 1 Hz, 3 Hz, 10 Hz (theta range), and 30 Hz (low-gamma
(at this latter frequency both genotypes showed sustained facilitation), at 10 Hz, Tau35
ack to baseline after the second pulse. Abbreviations: EPSPs, excitatory postsynaptic
retation of the references to color in this ﬁgure legend, the reader is referred to the Web
Fig. 4. Tau35 CA1-PCs had similar RMPs to WT neurons. Cumulative probability curve
showing cell-to-cell RMP probability in Tau35 and age-matched WT littermate con-
trols. No differences were observed between genotypes (see Table 1 for mean 
standard error of the mean and p-values). Abbreviations: RMP, resting membrane
potential; Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse.
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Two-way RM ANOVA showed an overall effect of genotype (be-
tween subjects) and voltage (within subjects) but no interaction
between genotype and voltage for Rin (genotype: F ¼ 6.06,
p ¼ 0.016; voltage: F ¼ 177.05, p < 0.0001; genotype*voltage:
F ¼ 0.933, p ¼ 0.34). Unpaired Student t test with Bonferroni
correction for multiple comparisons, revealed that Rin was not
signiﬁcantly different between genotypes when the prestimulus Vm
was held at 80 mV (Fig. 5A, see bottom panels), but it was
signiﬁcantly lower in Tau35 mice when the prestimulus Vm
was 74 mV (Fig. 5B, see bottom panels). In addition, capacitance
was signiﬁcantly higher in Tau35 mice at both tested prestimulus
Vm (Fig. 5, bottom panels), but no effect of voltage nor interaction
between genotype and voltage was observed (voltage: F ¼ 0,
p ¼ 0.99; genotype*voltage: F ¼ 0.510, p ¼ 0.478). No differences
were observed in other passive properties examined, such as sag
and s. The lack of change in s reﬂects the balancing of the w20%
increase in capacitance by a reciprocal decrease in Rin (although this
was not statistically signiﬁcant at 80 mV). See Table 1 for
mean  SEM, F, and p-values.
If an oscillating current of linearly increasing frequency and of
subthreshold intensity is injected, the oscillatory impedance prop-
erties of the cell can be explored. Our data showed that the cell
impedance (Z) was lower across the whole frequency spectrum, as
revealed by cell-to-cell analysis of AUC in frequency versus imped-
ance (Fig. 5C, right panel; Tau35, AUC ¼ 1747 Hz*MU  103 Hz*MU,
n ¼ 48; WT, AUC ¼ 2191 Hz*MU  153 Hz*MU, n ¼ 30, unpaired
Student t test p ¼ 0.01). This ﬁnding is in line with the lower Rin in
this group (Fig. 5 and Table 1). However, no signiﬁcant changeswere
observed in cell-to-cell analysis of peak Z, peak frequency, and the
quality factor of the resonator (Q), as summarized in Table 2
(showing mean  SEM and p-values).
Suprathreshold ﬁring properties were explored using 500 ms
duration step injections of depolarizing current. These ranged in
amplitude from 50 pA to 300 pA in 50 pA increments. As for the
determination of passive properties, these were applied from a
prestimulus membrane potential of both 80 mV and 74 mV.
With a prestimulus potential of 80 mV, no signiﬁcant differences
between genotypes were observed in the total spike output (Fig. 6A,
top panel; 2-way RM ANOVA, source of variability ¼ genotype,
F ¼ 1.121, Pbc ¼ 0.586) or dynamics of spike ﬁring. The latter is
illustrated for a 300 pA stimulus by the bottom panel of Fig. 6A(bottom panel; 2-way RM ANOVA, source of variability ¼ genotype,
F ¼ 0.820, Pbc ¼ 0.736). In contrast, when measured from a pres-
timulus membrane potential of 74 mV, the total spike output was
signiﬁcantly lower in Tau35 mice compared to age-matched WT
controls (Fig. 6B, top panel; 2-way RM ANOVA, source of
variability ¼ genotype, F ¼ 9.170, Pbc ¼ 0.006). This was also re-
ﬂected in the temporal dynamics of ﬁring as illustrated for a 300 pA
stimulus in the bottom panel of the ﬁgure (Fig. 6B 2-way RM
ANOVA, source of variability ¼ genotype, F ¼ 6.085, Pbc ¼ 0.032).
These results show a reduction of excitability of hippocampal CA1-
PCs in Tau35 mice, at slightly more depolarized RMPs.
As well as characterizing the extent and dynamics of
depolarization-induced AP ﬁring, we also investigated the
genotype-dependence of AP waveform as we (Brown et al., 2011;
Kerrigan et al., 2014; Tamagnini et al., 2015a,b) and others
(Wykes et al., 2012) have seen this change in other rodents exhib-
iting dementia-associated pathology. In this regard, we observed an
overall effect (2-way RM ANOVA) of genotype on the AP threshold,
but no effect of voltage nor interaction between genotype and
voltage (genotype: F ¼ 4.923, p ¼ 0.031; voltage: F ¼ 0.004,
p ¼ 0.948; genotype*voltage: F ¼ 1.816, p ¼ 0.183). Multiple com-
parisons between genotypes at each voltage revealed a 3-mV
hyperpolarization of the AP threshold in Tau35 mice versus
age-matched WT littermate controls for recordings made from a
prestimulus holding Vm ¼ 80 mV (Fig. 7C; unpaired t test with
Bonferroni correction for multiple comparisons, Pbc ¼ 0.006).
Although the AP threshold was 1.5 mV more hyperpolarized in
Tau35mice when current stimuli were delivered to cells at74mV,
this was not a signiﬁcant difference (Fig. 7D; unpaired t test with
Bonferroni correction for multiple comparisons, p ¼ 0.17). In addi-
tion, the rate of rise of the AP measured in each cell at 20 mV was
signiﬁcantly faster in Tau35 mice and slower (as an overall effect of
voltage across genotypes) at more depolarized potentials (Fig. 7E
and F; 2-way RM ANOVA for genotype: F ¼ 5.661, p ¼ 0.021;
voltage: F ¼ 4.197, p ¼ 0.045; genotype*voltage: F ¼ 0.124, p ¼
0.726). Unpaired Student t tests between genotypes with Bonfer-
roni correction for multiple comparisons at both prestimulus
potentials tested, revealed that the AP rate of rise was higher in
Tau35 mice at both tested potentials (Pbc ¼ 0.048 at 80 mV and
p ¼ 0.03 at 74 mV, respectively). AP width and AP peak were not
signiﬁcantly different between genotypes. For a summary of AP
waveform properties see Table 3. This observation allows us to
conclude that CA1-PCs from Tau35 are hyperexcitable, and this ef-
fect might be more pronounced at more polarized potentials. Series
resistance (Rs) was compensated for in each recording; Rs was not
different between genotypes (WT Rs¼ 13.5 0.3; Tau35 Rs¼ 13.5
0.4, unpaired Student t test p ¼ 0.97).
The changes to intrinsic excitability properties outlined above
likely have a signiﬁcant component of their basis in the underlying
ion channel complement of CA1 pyramidal cells (CA1-PCs). In the
past, we have studied changes of this nature in dementia models
using voltage clamp methods to characterize voltage-gated current
components (Brown et al., 2011). Notably, due to the complex ge-
ometry and size of pyramidal neurons, and the large currents they
express, using conventional whole-cell methods for such re-
cordings can have limited utility. To circumvent these issues, we
employed, as in our previous work (Brown et al., 2011), nucleated
somatic macropatches to examine voltage-gated channels. An
example of an outside-out, somatic macropatch excised from a CA1
cell in this study is shown in the top panel of Fig. 8A; example
voltage-gated outward Kþ currents are shown below (Fig. 8B).
Pooled data plotting the activated Kþ conductance versus voltage
relationships from 9 WT and 10 Tau35 macropatches are shown in
Fig. 8B. No effect of genotype was observed on Gmax (Fig. 8C; WT
n¼ 9, Gmax¼ 2.3 0.7 nS/pF vs Tau35 n¼ 11, Gmax¼ 1.2 0.4 nS/pF;
Fig. 5. Tau35 CA1-PCs have altered passive membrane properties. (A) and (B): Passive membrane properties of CA1-PCs were tested in Tau35 and age-matched WT littermate
controls with current-clamp whole-cell Vm recordings on the injection of a 100 pA, 500 ms current step at 2 different ﬁxed prestimulus potentials, 80 mV (A) and 74 mV (B),
obtained with a constant current injection. Top panels show the averaged standard error of the mean (SEM) Vm responses, whereas the bottom panels show scatter plots of cell-to-
cell analysis of the tested passive properties: Rin, s, capacitance, and sag. The boxes on the right of each scatter distribution (in this and following ﬁgures) represent the mean (small
square) median and SEM boundaries. Although capacitance was higher at both tested voltages, Rin was signiﬁcantly reduced only when tested at Vm ¼ 74 mV (unpaired Student’s t
test with Bonferroni correction: Pbc). (C) Impedance was reduced in the resonance proﬁle of Tau35 mice (right panel), obtained with the injection of a subthreshold sinusoidal
oscillating current with a frequency linearly increasing between 0.5 Hz and 20 Hz (left panel, bottom trace); the top traces in the left panel are representative examples, for each
genotype, of the Vm oscillating in response to the sinusoidal current injection. Abbreviation: Tau35, C-Terminal 35 kDa human tau fragment.
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the populations of macropatches from both genotypes. We did
observe, however, a striking and signiﬁcant shift in the voltage
dependence of Kþ current activation, which is better illustrated by
the peak-normalized conductance-voltage plots shown in Fig. 8D.
These highlight the 8 mV more negative activation curve seen in
Tau35 mice (Fig. 8C; WT n ¼ 9, V1/2 ¼ 14.81  2.05 mV vs. Tau35
n ¼ 11, V1/2 ¼ 23.15  1.87 mV; p ¼ 0.0076). The Boltzmann slope
factor of the current activation was not affected by genotype. These
results underlie and parallel the reduction of excitability observed
in Tau35 mice at more depolarized potentials.4. Discussion
Tauopathies are neurodegenerative disorders characterized by
the progressive accumulation of neurotoxic hyperphosphorylated
tau species within the CNS. Tauopathy is the major hallmark of
several neurodegenerative diseases that are predominantly char-
acterized by cognitive decline and dementia, for example Alz-
heimer’s disease and Pick’s disease. Tauopathy is also a cardinal
feature of certain diseases where cognitive decline is accompanied
by progressive development of motor deﬁcits, such as PSP and CBD
(Goedert and Spillantini, 2011; Iqbal et al., 2016; Lee et al., 2001;
Table 1
Passive membrane properties measured in CA1-PCs of Tau35 and WT mice at 2 prestimulus set potentials: Vm ¼ 80 mV and Vm ¼ 74 mV
Property WT (n ¼ 28e32) Tau35 (n ¼ 40e46) Pbc 2-Way RM ANOVA (genotype)
Mean SEM Mean SEM
Ri (MU) at Vm ¼ 80 mV 119.92 6.99 105.38 4.25 0.12 F ¼ 6.06 p ¼ 0.016
Ri (MU) at Vm ¼ 74 mV 141.74 7.65 120.10 5.12 0.03
sag (%) at Vm ¼ 80 mV 16.01 1.24 13.94 0.85 0.32 F ¼ 1.99 p ¼ 0.163
sag (%) at Vm ¼ 74 mV 12.50 1.43 10.43 0.97 0.43
s (ms) at Vm ¼ 80 mV 18.95 0.84 19.98 0.66 0.67 F ¼ 0.40 p ¼ 0.529
s (ms) at Vm ¼ 74 mV 22.06 1.14 22.50 0.83 1
Cap (pF) at Vm ¼ 80 mV 134.22 9.30 163.71 7.46 0.03 F ¼ 10.21 p ¼ 0.002
Cap (pF) at Vm ¼ 74 mV 132.52 8.68 167.08 7.05 0.005
Mean  standard error of the mean and p-values (unpaired Student t test with Bonferroni correction -Pbc-for multiple comparisons) are shown for each.
Key: Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse.
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et al., 2008). Even if some tauopathies are genetic disorders, most
of them are sporadic events, depending on both genetic (Mitsui and
Tsuji, 2014) and environmental risk factors. It has been shown, for
instance, that a highly phosphorylated 35 KDa fragment of tau
protein in human brain is associated with tauopathies, such as PSP
(Wray et al., 2008). Tau35 transgenicmicewere developed tomodel
the accumulation of the 35 KDa C-term fragment of human tau, and
the ﬁrst characterization of these mice was recently published. It
described neurological symptoms relating to both progressive
motor and cognitive decline paralleling the progressive tauopathy.
In addition, it showed the progressive accumulation of hyper-
phosphorylated pathogenic tau forms associated to the Tau35 ge-
notype, paralleled by GSK-3b accumulation and autophagy
impairment (Bondulich et al., 2016). In this respect, Tau35 mice can
perhaps be regarded as a ﬁrst model, expressing wild-type tau, of
sporadic tauopathies such as PSP, FTD, and CBD.
In this study, we have made a ﬁrst neurophysiological charac-
terization of Tau35 mice. We chose to examine the CA1 area of the
dorsal hippocampus as this has been widely studied in many de-
mentia models, and it is pertinent to the spatial memory deﬁcit
reported in these animals using the Morris water maze (Bondulich
et al., 2016). We examined the aspects of both synaptic function and
single cell intrinsic excitability properties in a single study cohort of
14- to 18-month-old Tau35 and age-matched WT littermate
controls.
Extracellular ﬁeld recordings of EPSPs indicated that brain slices
prepared from Tau35 mice exhibited normal theta bursteinduced
LTP in Schaffer collateral/CA1 synapses. LTP was also intact when
synaptic inputs to the deep dendrites of CA1 cells such as the
temporoammonic pathway were stimulated (Fig. 2). Although
these outcomes may be surprising for some, LTP in various hippo-
campal pathways has been reported to be intact in many transgenic
models of human dementia pathology, including both models of
amyloidopathy (Brown et al., 2005; Fitzjohn et al., 2001; Hsia et al.,Table 2
Subthreshold resonance membrane properties measured in CA1-PCs of Tau35 and
WT mice at 2 prestimulus set potentials: Vm ¼ 80 mV and Vm ¼ 74 mV
Property WT n ¼ 30 Tau35 n ¼ 48 p-value
Mean SEM Mean SEM
Peak Fr (Hz) 2.8 0.2 2.5 0.2 0.3
Peak Z (MU) 169.8 11.4 148.7 12.0 0.2
Q 1.07 0.01 1.05 0.01 0.4
AUC (MU*Hz) 1747 103 2191 153 0.01
Mean  SEM and p-values (unpaired Student’s t test) are shown for each.
Key: Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse.1999) and tauopathy (Booth et al., 2016b; Maeda et al., 2016;
Randall et al., 2010; Scott et al., 2016).
When the short-term facilitation of Schaffer collateral EPSPs was
tested with whole-cell current-clamp recordings of stimulus train-
evoked EPSPs in CA1-PCs, a difference in short-term synaptic
plasticity was seen. When EPSPs were drivenwith short 1 Hz trains,
the responses from the 2 genotypes were almost identical with a
20% response facilitation developing over the 6 pulse train. With 3-
Hz trains, Tau35 responses appeared to growmore, but this did not
quite reach a signiﬁcant level; however, a similar and statistically
signiﬁcant outcome was seen with 10-Hz synaptic activation. Thus,
in Tau35 mice, EPSPs both initially grew more and maintained their
increase throughout the train. This meant the overall depolarizing
envelope of the EPSP was some 55% larger. Interestingly, the fre-
quency at which EPSP facilitation is most striking, lies in the theta
frequency range, paralleling the most prominent in vivo hippo-
campal network oscillation in awake behaving rodents, and one
that is also impaired in other models of tauopathy (Booth et al.,
2016b).
It is interesting to consider the potential underlying mechanism
for the enhanced short-term plasticity at Schaffer collateral syn-
apses in Tau35 mice. This could reﬂect a lower basal probability of
release, and although extracellular recordings of input-output
curves did not suggest this, these could be affected by other fac-
tors including an enhanced axonal excitability. This hypothesis is in
line with the decrease in synapsin-1 we previously observed in
Tau35 (Bondulich et al., 2016) where we speculated that such
decrease might result in a selective loss of releasable vesicles but
not synaptophysin-regulated endocytosis of synaptic vesicles. This
result parallels the observation of reduced amplitude of 10 Hz
evoked EPSPs in cultured rat hippocampal neurons and drosophila
neuromuscular junctions, carrying mutations associated to familial
FTD (i.e., P301L on tau) (Zhou et al., 2017). The authors hypothesized
that this tauopathy-associated synaptic deﬁcit is caused by the
presynaptic interaction of the mutated tau N-terminus with
neurotransmitter-carrying vesicles. We observed an opposite result
in Tau35 mice CA1-PCs, where 10 Hz facilitation was in fact more
prominent in Tau35 mice in comparison to their WT littermates:
the Tau35 fragment is an N-terminus truncated, C-terminus pep-
tide, and the increased synaptic facilitation we observed might be
related to its accumulation. However, a more controlled and direct
experimental assessment of release probability would certainly be a
worthwhile endeavor. This could be achieved, for example, with
either emptage optical quantal methods or by studying the rate of
block of postsynaptic EPSPs with a non-competitive NMDA-R
antagonist such as MK-801. The time-course of the effect during
training, however, may point to an effect on presynaptic intracel-
lular Ca2þ handling. A reduced ability to dynamically buffer pre-
synaptic Ca2þ would likely produce an outcome akin to that
Fig. 6. Tau35 CA1-PCs are hypoexcitable at depolarized but not hyperpolarized potentials. The average (top panels) and instantaneous (bottom panels; only þ300 pA step is shown)
ﬁring frequencies of CA1-PCs were tested in Tau35 and age-matched WT littermate controls with current-clamp whole-cell Vm recordings on the injection of 500 ms, þ50 pA
to þ300 pA. Although no differences were observed between genotypes at Vm ¼ 80 mV (A), a signiﬁcant reduction of both average and instantaneous ﬁring frequencies was
observed in Tau35 mice at Vm ¼ 74 mV (B); such reduction in ﬁring rate at more depolarized potentials is probably a reﬂection of the respective reduction in Rin, as described in
Fig. 5A and B. Abbreviation: Tau35, C-Terminal 35 kDa human tau fragment.
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development of the present work, to use imaging to measure the
kinetics of presynaptic AP induced Ca2þ transients in CA3 pyramidal
cells.
If one embraces the well-established concept that an LTP-like
process is pivotal to the establishment of hippocampal-dependent
memory traces, one might ask how the normal LTP in Tau35 mice
can be reconciled with the deﬁcits these animals develop in a
hippocampal-dependent learning task (Bondulich et al., 2016). A
potential solution to this dichotomy lies in consideration of the
differences between the nature of a typical LTP experiment and
how synaptic plasticity is generated in vivo. In the experimental
situation, a stimulating electrode is used to simultaneously activate
many presynaptic ﬁbers both during the plasticity-inducing con-
ditioning stimulus (typically a 100 Hz train or theta burst stimulus)
and in the pre- and post-conditioning test periods. In vivo, however,
plasticity-inducing patterns of neural ﬁring are not produced by
stimulating electrodes, but they instead relate to the intrinsic
properties of the communicating neurons and how these shape
various aspects of on-going input to the cell. Consequently, disease-
associated changes to intrinsic properties could reduce or eliminate
the generation of particular patterns of ﬁring, including those
required to induce LTP-like synaptic plasticity. For this and other
reasons, we believe it is a useful endeavor to establish how intrinsic
neuronal properties are modiﬁed by pathologies, as we and others
have done in this and a number of other recent investigations(Booth et al., 2016a,b; Brown et al., 2011; Kerrigan et al., 2014;
Tamagnini et al., 2015a,b; Wykes et al., 2012).
No differences in CA1-PC RMP were observed when comparing
the genotypes. This agrees with our observations in another model
of tauopathy (Booth et al., 2016a,b) and our investigations of CA1-
PC in a variety of other models relating to human dementia
(Brown et al., 2011; Kerrigan et al., 2014; Tamagnini et al., 2015a,b).
Although RMP was not altered, we did uncover changes to other
intrinsic properties in experiments in which deﬁned current pulses
were injected into the cell via the recording electrode. These ex-
periments were performed from 2 set prestimulus membrane
potentials, 80 mV to match much of our previous work,
and 74 mV, which was closer to the mean RMP in this study. The
capacitance, calculated from the ratio of input resistance and
membrane time constant, was increased at both Vm tested. Indeed,
as this measure should predominantly arise from the surface area of
the cell and the insulating properties of the lipid bilayer, it would be
surprising if capacitances were found to be voltage-dependent. In
line with this, the values determined at the 2 Vm within each ge-
notype were within <2.5% of each other. The 20%e23% increase in
capacitance is probably due to the CA1-PCs in Tau35 mice being
larger. If the cells were a simple sphere, this would be expected to
equate to about a 6% increase in diameter or 12%e13% increase in
area, and although CA1-PC are geometrically muchmore complex, a
careful quantitative analysis of morphology would seemwarranted.
Another less likely possibility is that the dielectric properties of the
Fig. 7. Tau35 CA1-PCs have altered action potential kinetics. (A) and (B): Top panels show the averaged  standard error of the mean Vm responses corresponding to the ﬁrst AP ﬁred
on the injection of a 500 ms, þ300 pA recorded from CA1-PCs in Tau35 and age-matched WT littermate controls from a prestimulus potential of 80 mV (A) or 74 mV (B); middle
panels show the corresponding phase plots of the ﬁrst Vm derivative in time versus Vm: these show a visible difference in the rate of rise around a Vm ¼ 20 mV and hyperpo-
larization of the AP threshold, more clearly visible in the corresponding expanded phase plot in the bottom panel. (CeF). Cell-to-cell analysis of the AP waveform properties, revealed
a signiﬁcant increase of AP rate of rise at both 80 mv (E) and 74 mV (F) prestimulus Vm, while the AP threshold resulted signiﬁcantly hyperpolarized only at Vm ¼ 80 mV (C) but
not at Vm ¼ 74 mV (D); this could be due to a voltage-dependent dampening effect, the same one that provoked voltage-dependent decrease in Rin and ﬁring rate. Abbreviations:
AP, action potential; Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse.
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substantial change to the biochemical make-up of the lipid bilayer.
Membrane time constant, at around 20 ms, was very similar in
Tau35 and WT mice, but Rin was lower in the former group (thus
resulting in the calculated capacitance outcome as described pre-
viously). This lower Rin was only signiﬁcantly different (by 15%)at 74 mV, whereas the 12% decrease observed at 80 mV was not
signiﬁcant. It is possible that the decrease in Rin represents a
genomically mediated compensatory mechanism engaged by the
neurons tomaintain their membrane time constant in the face of an
increased capacitance. Commensurate with the expected Ohmic
consequences of a lower Rin (i.e., a smaller voltage change for any
Table 3
AP waveform properties measured in CA1-PCs of Tau35 and WT mice at 2 prestimulus set potentials: Vm ¼ 80 mV and Vm ¼ 74 mV. Mean  SEM and p-values (2-way
ANOVA and unpaired Student t test with Bonferroni correction -Pbc-for multiple comparisons) are shown for each
Property WT (n ¼ 26e29) Tau35 (n ¼ 30e41) Pbc 2-Way RM ANOVA (genotype)
Mean SEM Mean SEM
Width (ms) at Vm ¼ 80 mV 0.80 0.04 0.82 0.02 1 F ¼ 0.698 p ¼ 0.407
Width (ms) at Vm ¼ 74 mV 0.80 0.04 0.84 0.02 0.6
Peak (mV) at Vm ¼ 80 mV 21.59 2.10 23.24 1.53 1 F ¼ 0.690 p ¼ 0.410
Peak (mV) at Vm ¼ 74 mV 21.60 1.71 24.23 1.45 0.5
Thr (mV) at Vm ¼ 80 mV -64.53 0.71 -67.38 0.61 0.006 F ¼ 4.923 p ¼ 0.031
Thr (mV) at Vm ¼ 74 mV -63.46 0.62 -64.94 0.56 0.2
RoR (V/s) at Vm ¼ 80 mV 245.02 21.01 311.59 19.35 0.048 F ¼ 5.661 p ¼ 0.021
RoR (V/s) at Vm ¼ 74 mV 240.69 19.63 306.81 17.54 0.03
Key: AP, action potential; RoR, rate of rise; Tau35, C-Terminal 35 kDa human tau fragment; WT, wild-type mouse.
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spiking rates in CA1-PC at74mV (Fig. 6). In fractional terms, these
differences in spike output are greater with weaker current stimuli,
which are more likely to have physiological pertinence. Thus, spike
output is down by close to 50% when 50 pA is injected to cellsFig. 8. Activation of somatic noninactivating Kþ currents occurs at more negative potentia
excised from a CA1-PC of a Tau35 mouse to measure the biophysical properties of voltag
30 ms, þ40/þ60/þ80/þ100/þ120 mV voltage steps, from a prestimulus voltage clamped at
end of the voltage step stimulation. (C) Sigmoidal increase of IK speciﬁc conductance from a b
performed by calculating the maximal conductance (Gmax) and voltage-sensitivity (V1/2)
however, a signiﬁcant hyperpolarization of the V1/2 was observed in Tau35 CA1-PCs. This ca
measured G maximal value for each cell. (C) and (D) show mean  standard error of the m
values. Abbreviation: Tau35, C-Terminal 35 kDa human tau fragment.at 74 mV, whereas the difference is only circa 20% with a 300 pA
stimulus.
The observation of a genotype-related difference between
measurements made from 80 mV and 74 mV points to the
involvement of an ionic conductance that displays activation gatingls in Tau35 CA1-PCs. (A) Photograph of an outside-out nucleated somatic macropatch,
e-gated noninactivating outward currents (IK). (B) Example current traces evoked by
90 mV. After fast inactivating inward and outward currents, the IK persisted until the
aseline Vm ¼ 90 mV on 10-mV voltage steps. Analysis of IK biophysical properties was
with cell-to-cell Boltzman ﬁts. No effect of the genotype was observed on IK’s Gmax;
n be more clearly appreciated in (D), which shows the IV curve normalized versus the
ean values while the dashed lines represent the sigmoidal Boltzman ﬁt for the mean
Fig. 9. Schematic representation of the cascade of events potentially connecting Tau35 accumulation to altered intrinsic excitability of hippocampal CA1-PCs. Tau35 accumulation
results in activation of GSK-3b (Bondulich et al., 2016), which has been reported to decrease the gating potential of Kv7.2 channels and to increase Nav1.6 docking on the AIS via the
AIS-associated protein AnkG. These events might be responsible for the reduced intrinsic excitability observed in Tau35 mice. Hyperpolarization of Kv7.2 channels V1/2 could reduce
input resistance and AP ﬁring rate at depolarized potentials, whereas increased docking of Nav1.6 channels to the axonal initial segment could reduce the AP threshold and increase
the AP maximal rate of rise. The causal relationship between these electrophysiological alterations and the cognitive decline observed in the Tau35 model of sporadic tauopathy
remains to be clariﬁed. Abbreviations: AIS, axonal initial segment; AnkG, ankyrin G; AP, action potential; GSK-3b, glycogen synthase kinase 3b; Kv 7.2, voltage-gated Kþ channels 7.2;
Nav 1.6, voltage-gated Naþ channels 1.6; Rin, input resistance; ROR, max rate of rise; Tau35, C-Terminal 35 kDa human tau fragment; Thr, Threshold; V1/2, half-activation potential;
Vm, membrane potential.
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ductances that fulﬁll this criteria in CA1-PCs, namely HCN channels
and Kv7 channels. The presence of HCN channels is reﬂected in the
higher Rin seen at 74 mV than 80 mV (something known clas-
sically as anomalous rectiﬁcation), as well as the voltage “sag”
observed when negative current is injected into the cells to hy-
perpolarize them. We recently reported changes to voltage sag in a
different model of tauopathy (Booth et al., 2016a,b), although the
lack of genotype-related differences in this parameter in this model
argues against, but perhaps does not entirely rule out, changes to
HCN channels in Tau35 mice.
Our observations are consistentwith the presence ofmore active
Kv7 channels in the Tau35 mice. These voltage-gated Kþ channels,
which are responsible for the so-called M-current, are tonically
active at rest in CA1-PCs and are turned onby furtherdepolarization.
Our observations of a lower Rin in Tau35 at 74 mV could reﬂect
either a larger total number of channels in Tau35 mice or alterna-
tively a negative shift in the voltage dependence of channel opening.
To date these have mainly been studied in the context of cancer
epigenetics (Benoit et al., 2014). Notably, however, Tau35 mice have
been shown to display increased GSK-3b activity (Bondulich et al.,
2016), and this kinase is reported to modulate the gating proper-
ties of Kv7.2 channels via phosphorylation (Cooper et al., 2001;
Singh et al., 1998; Wildburger and Laezza, 2012). In pyramidal
neurons of the medial prefrontal cortex, inhibition of GSK-3b pro-
duces a hyperexcitability that mimics and occludes the effect of a
Kv7 antagonist (Kapfhamer et al., 2010). Consequently, we hypoth-
esize that in Tau35 mice activation of Kv7 channels by GSK-3b-
dependent phosphorylation can modify excitability in CA1-PCs.
Our voltage clamp recordings comparing Kþ currents in somatic
macropatches from WT and Tau35 mice are certainly supportive ofa negative shift in activation gating of a population of non-
inactivating voltage-gated Kþ channels. However, we do not know
what components of these currents, if any, result from activity of
Kv7 channels. Some evidence indicates that Kv7 channels can be
localized on the soma both with functional (Shah et al., 2011) and
immunohistochemical measures (Cooper et al., 2001; Roche et al.,
2002). However, these channels are thought to be more strongly
localized on the axonal initial segment (AIS) and nodes of Ranvier.
We also observed an increase in AP rate of rise in Tau35 mice.
This was seen from both prestimulus membrane potentials exam-
ined. We also observed a hyperpolarization of the AP threshold in
Tau35 animals but only when the cells were at 80 mV prior to the
stimulus. However, the voltage dependence of AP threshold change
between genotypes should be consideredwith caution, as one value
among the 74 mV, Tau35 population appears to be an outlier and
its removal would bring the AP threshold to be signiﬁcantly
hyperpolarized in Tau35 mice at both tested potentials. These al-
terations to AP properties could also result from the activity of GSK-
3b, which has been shown to increase docking of Ankyrin-G, which
results in elongation of the AIS and an increased surface density of
Nav1.6 channels. In fact, GSK-3b has been shown to promote the
elongation of the AIS and the reduction of the AIS distance from the
soma via increased Ankyrin-G docking, changing the AP waveform
properties and cell excitability (Tapia et al., 2013). Fig. 9 illustrates
the mechanistic pathway potentially underlying our observations.
Previous work showed a striking increase of CA1-PCs
Ih-dependent resonance properties in rTg4510 mice (Booth et al.,
2016b), particularly increased Peak Fr and Q, but no changes in
impedance. Here, although no differences were observed in Peak Fr
and Q, the overall impedance, measured as area under curve, was
signiﬁcantly smaller in Tau35, probably as a consequence of
F. Tamagnini et al. / Neurobiology of Aging 60 (2017) 44e56 55reduced input resistance at depolarized potentials, possibly medi-
ated by IM or other noninactivating Kþ currents. This could be
interesting evidence suggesting how different forms of pathogenic
tau can differentially affect neuronal resonance.
The bidirectionality of excitability, depending on membrane
potential, is an interesting observation. Although studies carried
out on genetic models of frontotemporal dementia, such as rTg4510
mice, reveal an overall reduction of hippocampal network activity,
presumably due to cell death (Booth et al., 2016b), other research
works carried out on transgenic mice bearing a transgene associ-
ated to increased risk of sporadic frontotemporal dementia, reveal
hippocampal hyperexcitability (Maeda et al., 2016; Siskova et al.,
2014). Our observations reveal that single-cell excitability in CA1-
PCs may change with membrane potential in Tau35 mice,
presumably decreasing during the raising phase of the wave and
vice-versa; however, to causally relate these results to network
alterations, an in vivo study involving electrophysiological re-
cordings preferably in behaving animals is required. In particular, it
has been shown that the administration of the histone deacetylase
(HDAC) inhibitor 4-phenyl butyrate in Tau35 mice results in the
reduction of cognitive and motor impairment, GSK-3b activation
and the associated hyperphosphorylation of tau protein; a key
experiment, for exploring the mechanistic correlates of Tau35
altered electrophysiology described in this work, will be to test
CA1-PC excitability and in vivo hippocampal network activity in 4-
phenyl butyrate treated animals.
In summary, we have identiﬁed a range of neurophysiological
consequences in hippocampal neurons associated with the Tau35
genotype. Although experimentally induced LTP is intact, we
observed an increase and decrease of excitability of Tau35 CA1-PCs
at polarized and depolarized membrane potentials, respectively.
We hypothesize that this change is mediated by the phosphoryla-
tion of Kv7 and Nav1.6 channels, respectively, as increased GSK-3b
activity is observed in Tau35 mice (Bondulich et al., 2016). A more
detailed mechanistic characterization will be necessary to establish
the causative role of GSK-3b in the electrophysiological alterations
described in this work.Disclosure statement
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